Final height of Japanese patients with X-linked hypophosphatemic rickets: Effect of vitamin D and phosphate therapy

Endocrine Journal

Volumn 47, Issue 2, 2000, Pages 163-167

  Miyamoto, Junko ^a   Koto, Shinobu ^a   Hasegawa, Yukihiro ^a,b,c  

^a Endocrinol Metab and Genet Unit   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Endocrinol Metab and Genet Unit   (Japan)

Author keywords

Final height; Japanese; Phosphate; Vitamin D; XLH

Indexed keywords

PHOSPHATE; VITAMIN D;

ADULT; ARTICLE; BODY HEIGHT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHOSPHATEMIA; JAPAN; MALE; RICKETS; VITAMIN D RESISTANT RICKETS;

EID: 0034045365     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.47.163     Document Type: Article

References (15)

1. Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303(18): 1023-1031.
2. Stickler GB, Morgenstern BZ (1989) Hypophosphatemic rickets: final height and clinical symptoms in adults. Lancet 2(8668): 902-905.
3. Stamp T, Goldstein AJ (1990) Hypophosphataemic rickets and final height. Lancet 335(8688): 536-537. letter
4. 3 until completion of the growth. Nippon Seikeigeka Gakkai Zasshi 66(11): 1137-1345.
5. Berndt M, Ehrich JH, Lazovic D, Zimmermann J, Hillmann G, Kayser C, Prokop M, Schirg E, Siegert B, Wolff G, Brodehl J (1996) Clinical course of hypophosphatemic rickets in 23 adults. Clin Nephrol 45(1): 33-41.
6. Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JH, Brodehl J (1990) X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Arch Dis Child 65(10): 1125-1128.
7. Koto S (1991) Participation of disturbed vitamin D metabolism in pathogenesis of hypophosphatemic vitamin D-resistant rickets. Nihon shounika gakkai zasshi 95(12): 2592-2599 (in Japanese).
8. Suwa S, Tachibana K, Maesaka H, Yokota S (1992) Longitudinal Standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol 1: 5-13.
9. Ogata T, Matsuo N, Tamai S, Osano M, Tanngo T (1990) Target range of Japanese: set up target height and target range. Nihon shounika gakkai zasshi 94: 1535-1540 (in Japanese).
10. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325: 1843-1848.
11. Seikaly MG, Browne RH, Baum M (1994) The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia. Pediatrics 94: 478-481.
12. 3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 75(3): 879-885.
13. Dumas R, Guermoud C, Garabedian M, Meunier JP (1985) Biological and bone histomorphometric studies in hypophosphatemic vitamin-resistant rickets treated with 1,25-(OH)2D and phosphorus. Arch Fr Pediatr 42(7): 507-510.
14. Balsan S, Tieder M (1990) Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: Influence of treatment regimen and parental height. J Pediatr 116: 365-371.
15. McEnery PT, Silverman FN, West CD (1972) Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets. J Pediatr 80(5): 763-774.